Massachusetts Litigation Tallies 2,700 GranuFlo Recall Suits in February, Bernstein Liebhard LLP Reports
New York, NY (PRWEB) February 22, 2015 -- Nearly 2,700 GranuFlo recall (http://www.granuflolawsuit2014.com/) lawsuits are now pending in the District of Massachusetts, where a federal litigation involving two Fresenius dialysis medications is now underway, Bernstein Liebhard LLP reports.
According to court documents updated on February 17th, at least 2,686 claims over GranuFlo and NaturaLyte have been filed in the proceeding against Fresenius Medical Care. Lawsuits centralized in this litigation allege strokes, heart attacks, sudden cardiac death and other serious heart events following use of the acid concentrates, which are used in dialysis. All of the GranuFlo and NaturaLyte cases centralized in Massachusetts were filed after a dialysis recall in 2012 that was issued after side effects of the medications were found to be serious, and potentially life-threatening. (In re: Consolidated Fresenius Cases, No. MICV2013-03400-O).
“Our Firm is representing numerous individuals in GranuFlo and NaturaLyte lawsuits that have been filed in Massachusetts federal court. It’s noteworthy that nearly three years after a recall of these medications, the litigation is continuing to progress. In fact, court documents indicate that in the past month, more than 100 new filings have been added to the litigation” says Bernstein Liebhard LLP, a nationwide law firm representing defective medical devices and drugs including GranuFlo. The Firm is currently evaluating GranuFlo and NaturaLyte lawsuits on behalf of individuals who were allegedly injured by the dialysis medication.
GranuFlo and NaturaLyte Litigation
The federal GranuFlo litigation is steadily moving forward with nearly 2,700 lawsuits filed against Fresenius Medical Care, court documents indicate. These claims allege catastrophic heart events caused by the medications, which were subject to a recall in June 2012 by the U.S. Food and Drug Administration (FDA). This federal action was taken after regulators found side effects of GranuFlo and NaturaLyte to be severe, and potentially very dangerous. Two months earlier, an Urgent Product Notification was issued by Fresenius that notified users about the drugs’ association with metabolic alkalosis, a condition that follows elevated levels of bicarbonate in the blood stream.
A New York Times report published around the time of the recall called attention to an internal memo Fresenius sent physicians operating in its dialysis clinics in November 2011, several months before its official notice to consumers. Upon learning of this document, the FDA had launched into an investigation of whether Fresenius violated federal regulations in its concealment of numerous dialysis deaths they knew about.
Plaintiffs involved in GranuFlo lawsuits now pending in Massachusetts federal court accuse Fresenius of marketing the drug even after its heart risks were made known.
Individuals who used GranuFlo or NaturaLyte and went on to suffer a serious cardiovascular heart event within 72 hours of administration may be eligible to file a lawsuit that seeks compensation from their manufacturer, Fresenius Medical Care. Learn more about the GranuFlo recall of 2012 when you visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/granuflolawsuit. For additional information, and to arrange for a free case review, please call 800-511-5092.
*nytimes.com/2012/06/15/health/fda-investigates-fresenius-for-failure-to-warn-of-risk.html?_r=0, New York Times, June 15, 2012
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.granuflolawsuit2014.com/
https://plus.google.com/115936073311125306742?rel=author
Felecia L. Stern, GranuFlo Dialysis Treatment Lawsuit Center, http://www.granuflolawsuit2014.com/, +1 800-511-5092, [email protected]
Share this article